alrestatin has been researched along with Cataract in 3 studies
alrestatin: aldose reductase inhibitor; RN given refers to parent cpd; structure
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kador, PF | 2 |
| Kinoshita, JH | 2 |
| Sharpless, NE | 1 |
| Tung, WH | 2 |
| Chylack, LT | 2 |
| Henriques, HF | 1 |
| Cheng, HM | 1 |
1 review available for alrestatin and Cataract
| Article | Year |
|---|---|
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; | 1985 |
2 other studies available for alrestatin and Cataract
| Article | Year |
|---|---|
Differences in the susceptibility of various aldose reductases to inhibition. II.
Topics: Aldehyde Reductase; Animals; Cataract; Chromones; Female; Humans; Imidazoles; Imidazolidines; Isoqui | 1980 |
Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
Topics: Aldehyde Reductase; Cataract; Cataract Extraction; Diabetes Complications; Glucose; Humans; Isoquino | 1979 |